Targeting brain lipid homeostasis to treat Alzheimer's disease. Dementia affects approximately 250,000 people in Australia at an estimated cost (in 2002) of $6.6 billion per annum. The major cause of dementia (accounting for approximately 70% of all cases) is Alzheimer's disease (AD); a progressive neurodegenerative illness for which there is no curative or disease-stalling treatment. Due to increases in life expectancy, the incidence of AD is predicted to triple by 2050 unless disease-modifying ....Targeting brain lipid homeostasis to treat Alzheimer's disease. Dementia affects approximately 250,000 people in Australia at an estimated cost (in 2002) of $6.6 billion per annum. The major cause of dementia (accounting for approximately 70% of all cases) is Alzheimer's disease (AD); a progressive neurodegenerative illness for which there is no curative or disease-stalling treatment. Due to increases in life expectancy, the incidence of AD is predicted to triple by 2050 unless disease-modifying treatments are developed. This research program will provide novel realistic pharmaceutical approaches to treat AD. Even if the onset of AD could be delayed by a few years the personal and financial benefits would be enormous. The potential for this research to generate commercially viable Australian intellectual property is also significant.Read moreRead less
Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers. Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation st ....Improved identification of patients 'at risk' of depression, and optimal targeting of rehabilitation post-stroke through novel brain imaging and biomarkers. Use of novel brain imaging and biomarkers for identification of stroke survivors at risk of depression and recurrent stroke will permit early access to preventative and effective treatments for depression and improve capacity to benefit from rehabilitation. Development of predictive models to guide selection of most optimal rehabilitation strategies based on viable brain will maximise the capacity for persons with stroke to reach their full potential for recovery and ensure rehabilitation is more targeted and cost efficient. Improved capacity to benefit from treatment will have ongoing benefits for activity participation and productive living in Australians who experience stroke.Read moreRead less
The Genetic Analysis of Neurological Diseases. Multiple sclerosis and Parkinson's are debilitating neurodegenerative diseases, which affect 16,000 and 80,000 Australians, respectively. Between them, these diseases cost the community $7.8 billion per annum, and there is no cure. This proposal will study the genes that influence a person's predisposition to developing these diseases, and what makes some people have particular characteristics. It will provide novel insights into the diseases themse ....The Genetic Analysis of Neurological Diseases. Multiple sclerosis and Parkinson's are debilitating neurodegenerative diseases, which affect 16,000 and 80,000 Australians, respectively. Between them, these diseases cost the community $7.8 billion per annum, and there is no cure. This proposal will study the genes that influence a person's predisposition to developing these diseases, and what makes some people have particular characteristics. It will provide novel insights into the diseases themselves and information that could help in the development of new and more effective drugs, and biomarkers to assist in the prediction of prognosis. Such advances would decrease the economic impact of these diseases and improve quality of life for those affected.Read moreRead less
Imaging genetics in schizophrenia and bipolar disorder: shared neurocognitive endophenotypes. Combined, schizophrenia and bipolar disorder afflict approximately 506,000 Australians at any one time, and are leading causes of disability and national economic burden. This study will delineate genetic underpinnings for these conditions in association with specific neurocognitive dysfunctions that are common to both disorders. These findings have important implications for the implementation of perso ....Imaging genetics in schizophrenia and bipolar disorder: shared neurocognitive endophenotypes. Combined, schizophrenia and bipolar disorder afflict approximately 506,000 Australians at any one time, and are leading causes of disability and national economic burden. This study will delineate genetic underpinnings for these conditions in association with specific neurocognitive dysfunctions that are common to both disorders. These findings have important implications for the implementation of personalised pharmaceutical treatments on the basis of genotype, and the development of therapeutic agents to target cognitive function. These results will also aid detection of premorbid psychotic illness in young individuals who may benefit from early intervention that may thwart the illness trajectory. Read moreRead less
Improving Outcome after Stroke through Earlier Rehabilitation: The Very Early Rehabilitation Research Program. Stroke presents a major, growing global public health challenge accounting for 25% of all chronic disability. Treatments that reduce the burden of stroke are urgently needed, and early rehabilitation may significantly reduce chronic disability. A large, high quality, National Health and Medical Research Council funded clinical trial is at the heart of the A Very Early Rehabilitation Tri ....Improving Outcome after Stroke through Earlier Rehabilitation: The Very Early Rehabilitation Research Program. Stroke presents a major, growing global public health challenge accounting for 25% of all chronic disability. Treatments that reduce the burden of stroke are urgently needed, and early rehabilitation may significantly reduce chronic disability. A large, high quality, National Health and Medical Research Council funded clinical trial is at the heart of the A Very Early Rehabilitation Trial (AVERT) program. The trial tests whether a simple, rehabilitation intervention (early and intensive out of bed activity) results in fewer deaths and less disability for stroke sufferers and is cost effective. If effective the intervention could be adopted across different health services both here and overseas, reducing the global burden of stroke.Read moreRead less
The articulate brain. Language is essential to human interaction, yet we know comparatively little about the mental processes involved and how they are represented in the brain, how genetic and environmental factors contribute to the development of language, or how effective treatments of language disorders work. The significance of this program of research lies in its capacity to enhance our understanding of a range of mechanisms responsible for a fundamentally human ability, and provide inform ....The articulate brain. Language is essential to human interaction, yet we know comparatively little about the mental processes involved and how they are represented in the brain, how genetic and environmental factors contribute to the development of language, or how effective treatments of language disorders work. The significance of this program of research lies in its capacity to enhance our understanding of a range of mechanisms responsible for a fundamentally human ability, and provide information that will ultimately inform clinical practice. In particular, new knowledge about the brain mechanisms involved in language processing and recovery will inform clinicians about the optimal choice of treatment to maximise outcomes for the individual patient. Read moreRead less
The human mirror system and the perception of others' actions. This research will provide greater understanding of how the human mirror system operates for the perception of actions, a crucial first-step toward understanding disorders of action perception such as autism and apraxia. The research program will also contribute greatly to building national capacity in cognitive neuroscience research, using advanced brain imaging methods. The fellow actively encourages and mentors young scientists, o ....The human mirror system and the perception of others' actions. This research will provide greater understanding of how the human mirror system operates for the perception of actions, a crucial first-step toward understanding disorders of action perception such as autism and apraxia. The research program will also contribute greatly to building national capacity in cognitive neuroscience research, using advanced brain imaging methods. The fellow actively encourages and mentors young scientists, organises advanced workshops that bring brain imaging researchers around the world to Australia, and builds international collaborations based around high-field brain imaging. The Future Fellowship will substantially enhance these activities, building capacity and enhancing Australia's reputation in cognitive neurosciences.Read moreRead less
Understanding the neuronal mechanisms underlying inherited epilepsies. Epilepsy is a serious disease that impacts severely on individuals and the community as a whole. Conservative estimates suggest a financial cost of more than $2 billion per annum. Drug treatment for this disease is often not adequate. Recent advances have allowed scientists to determine mutation in human genes that cause epilepsy. New models of epilepsy based on this knowledge will allow us to better understand what causes e ....Understanding the neuronal mechanisms underlying inherited epilepsies. Epilepsy is a serious disease that impacts severely on individuals and the community as a whole. Conservative estimates suggest a financial cost of more than $2 billion per annum. Drug treatment for this disease is often not adequate. Recent advances have allowed scientists to determine mutation in human genes that cause epilepsy. New models of epilepsy based on this knowledge will allow us to better understand what causes epilepsy enabling us to devise new and potent therapeutic strategies to treat the disease.Read moreRead less
Identifying novel roles of disease-related proteins in the regulation of exocytosis and nervous communication. This research aims to identify new molecules involved in regulating nerve communication and hormone secretion and which are relevent to human diseases and conditions including Type 2 Diabetes, Down Syndrome, Alzheimer's Disease and Huntington's Disease. The findings may provide new targets in the treatments of such conditions. This research is therefore of special relevance to National ....Identifying novel roles of disease-related proteins in the regulation of exocytosis and nervous communication. This research aims to identify new molecules involved in regulating nerve communication and hormone secretion and which are relevent to human diseases and conditions including Type 2 Diabetes, Down Syndrome, Alzheimer's Disease and Huntington's Disease. The findings may provide new targets in the treatments of such conditions. This research is therefore of special relevance to National Research Priority 2: Promoting and Maintaining Good Health and especially to the sub-areas of this Research Priority 2: Ageing well, ageing productively and Preventative healthcare.Read moreRead less